( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Priya Satheesh, P. Thennarasu*, N. Vanitha Rani and P. Soundararajan


In India, majority of patients with End stage renal disease (ESRD) can afford only hemodialysis and the cost of maintenance hemodialysis (MHD) differs across the country. A study was conducted in 108 patients aged 18years or older, on MHD to assess the cost of illness and its impact on quality of life of patients on MHD. The medical costs were collected from various units of the hospital and the prescription was analyzed to assess the cost factor involved in the medications. Non- medical costs and indirect costs were collected from the patients directly. The Quality of Life (QOL) was assessed using Short form 36 questionnaire. The data collected was analyzed with SPSS 17.0 version. Paired t-test was used to find the significant difference and Pearson's correlation was used to assess the relationship between the variables. A probability value of P ≤ 0.05 was considered as statistically significant. The average cost per session was found to be Indian Rupee (INR) 1500, this included the dialysis session cost only excluding all other costs. The mean total annual cost of dialysis per patient was estimated to be INR 5, 42,299. The cost factor for direct medical expense amounted to INR 52,420 per month, direct non-medical cost amounted to INR 6,856 per month and the indirect cost amounted to INR 6,759 per month. Apart from this monthly cost, there were additional expenses in direct medical cost which included ICU admissions costs for major complications, hospitalization costs for access procedures and for other complications. Erythropoietin contributed to 81% of the total drug cost spent by MHD patients. The physical component showed a higher score compared to the mental component of health related QOL. There was a significant correlation between cost of illness and physical/mental components of health related QOL. This study identified that direct costs were momentous when compared to indirect costs. This information can form a basis for further pharmacoeconomic studies.

Keywords: End stage renal disease, chronic kidney disease, maintenance hemodialysis, renal replacement therapy, quality of life.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 July 2024 Issue has been Published, Kindly check it on


    JULY 2024 issue has been successfully launched on JULY 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia